Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Gary, Kay"'
Autor:
Shengfang Su, Gary Kay, Thomas Hochadel, Jonathan Rojo, J. Christopher Stein, Ramesh Boinpally, Antonia Periclou
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 1, Pp 255-266 (2022)
Abstract N‐methyl‐D‐aspartate ionotropic glutamatergic receptor (NMDAR) modulators, including rapastinel and ketamine, elicit rapid and sustained antidepressant responses in patients with treatment‐resistant major depressive disorder. This ph
Externí odkaz:
https://doaj.org/article/fe9890dada6f4de299e28d7142b64b90
Autor:
Jonas Hannestad, Katie Koborsi, Vicki Klutzaritz, Whitney Chao, Rebecca Ray, Antonio Páez, Sam Jackson, Scott Lohr, Jeffrey L. Cummings, Gary Kay, Karoly Nikolich, Steven Braithwaite
Publikováno v:
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 6, Iss 1, Pp n/a-n/a (2020)
Abstract Introduction This phase 2 trial evaluated the safety, tolerability, and feasibility of repeated infusions of the plasma fraction GRF6019 in mild‐to‐moderate Alzheimer's disease. Methods In this randomized, double‐blind, dose‐comparis
Externí odkaz:
https://doaj.org/article/c4603e6c5f5043ecbaa828fafa71bfd2
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics
What is known and objective Tolperisone is a centrally acting muscle relaxant under development in the United States as a treatment for acute and painful symptoms of muscle spasms. The objective of this three‐way, randomized, blinded, three‐perio
Autor:
Whitney Chao, Brian Beck, Katie Koborsi, Steven P. Braithwaite, Vicki Klutzaritz, Karoly Nikolich, Jonas Hannestad, Gary Kay, Ashok K. Patel, Stephen G. Thein, Tiffanie Duclos, James Scott, Jeffrey L. Cummings
Publikováno v:
Journal of Alzheimer's disease : JAD. 81(4)
Background: The plasma fraction GRF6019 shows multiple benefits on brain aging in mice, including enhanced cognition, neurogenesis, and synaptic density, as well as reduced neuroinflammation. Objective: To evaluate the safety, tolerability, and preli
Autor:
Haitham S. Al Ashry, Hugi Hilmisson, Yuenan Ni, Robert J. Thomas, Clete A. Kushida, Deborah A. Nichols, Eileen B. Leary, Pamela R. Hyde, Tyson H. Holmes, Daniel A. Bloch, William C. Dement, Rik Jadrnicek, Ric Miller, Usman Aijaz, Aamir Farooq, Darryl Thomander, Chia-Yu Cardell, Emily Kees, Michael E. Sorel, Oscar Carrillo, Tami Crabtree, Ray Balise, Tracy Kuo, Rhonda M. Wong, Pete Silva, Max Hirshkowitz, Alan Gevins, Gary Kay, Linda K. McEvoy, Cynthia S. Chan, Sylvan Green, Christian Guilleminault, David Claman, Stephen Brooks, Julianne Blythe, Jennifer Blair, Pam Simi, Ronelle Broussard, Emily Greenberg, Bethany Franklin, Amirah Khouzam, Sanjana Behari Black, Viola Arias, Romelyn Delos Santos, Tara Tanaka, Stuart F. Quan, James L. Goodwin, Wei Shen, Phillip Eichling, Rohit Budhiraja, Charles Wynstra, Cathy Ward, Colleen Dunn, Terry Smith, Dane Holderman, Michael Robinson, Osmara Molina, Aaron Ostrovsky, Jesus Wences, Sean Priefert, Julia Rogers, Megan Ruiter, Leslie Crosby, Richard D. Simon, Kevin Hurlburt, Michael Bernstein, Timothy Davidson, Jeannine Orock-Takele, Shelly Rubin, Phillip Smith, Erica Roth, Julie Flaa, Jennifer Schwartz, Anna Simon, Amber Randall, James K. Walsh, Paula K. Schweitzer, Anup Katyal, Rhody Eisenstein, Stephen Feren, Nancy Cline, Dena Robertson, Sheri Compton, Susan Greene, Kara Griffin, Janine Hall, Daniel J. Gottlieb, David P. White, Denise Clarke, Kevin Moore, Grace Brown, Paige Hardy, Kerry Eudy, Lawrence Epstein, Sanjay Patel
Publikováno v:
Annals of the American Thoracic Society. 18(5)
Rationale: The increased prevalence of obstructive sleep apnea (OSA) coincides with a severe shortage of sleep physicians. There is a need for widescale home-sleep-testing devices with accurate aut...
Autor:
Steven P. Braithwaite, Whitney Chao, Vicki Klutzaritz, Samuel J. Jackson, Scott Lohr, Gary Kay, Jonas Hannestad, Rebecca Ray, Antonio Páez, Katie Koborsi, Jeffrey L. Cummings, Karoly Nikolich
Publikováno v:
Alzheimer's & Dementia : Translational Research & Clinical Interventions
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 6, Iss 1, Pp n/a-n/a (2020)
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 6, Iss 1, Pp n/a-n/a (2020)
Introduction This phase 2 trial evaluated the safety, tolerability, and feasibility of repeated infusions of the plasma fraction GRF6019 in mild‐to‐moderate Alzheimer's disease. Methods In this randomized, double‐blind, dose‐comparison trial,
Autor:
Karl K, Johe, Gary, Kay, Santosh, Kumar, Katherine E, Burdick, Roger S, McIntyre, George I, Papakostas, Maurizio, Fava
Publikováno v:
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. 32(3)
NSI-189 phosphate (NSI-189) is a novel neurogenic molecule with pleiotropic properties, including antidepressant, procognitive, synaptoplastic, and neurotrophic activities demonstrated in preclinical studies. Its antidepressant activity is monoamine-
Autor:
Jessica Berrett, Joseph Djan, Jamie Reiter, Donald J. Connor, Gary Kay, David J. Carpenter, Rebecca D. Crean
Publikováno v:
Alzheimer's & Dementia. 12
Autor:
GARY, KAY
Publikováno v:
ETC: A Review of General Semantics, 1973 Dec 01. 30(4), 423-426.
Externí odkaz:
https://www.jstor.org/stable/42576386
Autor:
William C. de Groat, Gary Kay, Paul Abrams, Pankaj J. Pasricha, Karl-Erik Andersson, Alan M. Laties, Alan J. Wein, Jerry J. Buccafusco, Christopher R. Chapple, Alison D. Fryer, Neil M. Nathanson
Publikováno v:
British Journal of Pharmacology. 148:565-578
1 The effectiveness of antimuscarinic agents in the treatment of the overactive bladder (OAB) syndrome is thought to arise through blockade of bladder muscarinic receptors located on detrusor smooth muscle cells, as well as on nondetrusor structures.